{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=13", "query": { "intervention": "AS+", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 48379, "total_pages": 4838, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T03:30:20.685Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05180500", "title": "Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID-19", "Pharmacokinetics", "Safety" ], "interventions": [ { "name": "Q-Griffithsin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sharon Hillier", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 50, "start_date": "2022-03-15", "completion_date": "2022-12-07", "has_results": true, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05180500" }, { "nct_id": "NCT01325207", "title": "Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Trastuzumab", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2011-08-01", "completion_date": "2019-01-20", "has_results": true, "last_update_posted_date": "2019-09-26", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 8, "location_summary": "San Francisco, California • Chicago, Illinois • Boston, Massachusetts + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01325207" }, { "nct_id": "NCT02250911", "title": "Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Caregivers" ], "interventions": [ { "name": "webcasts", "type": "OTHER" }, { "name": "Assessments", "type": "BEHAVIORAL" }, { "name": "Usual care", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2014-09", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2018-08-10", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02250911" }, { "nct_id": "NCT04392011", "title": "Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Interaction Drug Food" ], "interventions": [ { "name": "Midazolam HCl", "type": "DRUG" }, { "name": "Dextromethorphan HBr", "type": "DRUG" }, { "name": "Kratom", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Washington State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 15, "start_date": "2019-10-09", "completion_date": "2021-08-31", "has_results": true, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "Spokane, Washington", "locations": [ { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04392011" }, { "nct_id": "NCT03860311", "title": "BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Point-of-Care Bladder Ultrasound", "Urethral Catheter" ], "interventions": [ { "name": "Bladder Ultrasound", "type": "DEVICE" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "FEMALE", "summary": "8 Years to 18 Years · Female only" }, "enrollment_count": 45, "start_date": "2019-07-20", "completion_date": "2021-05-01", "has_results": true, "last_update_posted_date": "2022-06-01", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03860311" }, { "nct_id": "NCT04137731", "title": "Use of Interferential Current (IFC) Therapy After Total Knee Arthroplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteo Arthritis Knee" ], "interventions": [ { "name": "Interferential Current Therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-12-05", "completion_date": "2022-08-15", "has_results": true, "last_update_posted_date": "2023-09-08", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04137731" }, { "nct_id": "NCT04165031", "title": "A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor", "Non-Small Cell Lung Cancer", "Colorectal Cancer" ], "interventions": [ { "name": "LY3499446", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Cetuximab", "type": "DRUG" }, { "name": "Erlotinib", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2019-11-28", "completion_date": "2020-10-30", "has_results": true, "last_update_posted_date": "2021-11-24", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 4, "location_summary": "Indianapolis, Indiana • Middletown, New Jersey • Harrison, New York + 1 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04165031" }, { "nct_id": "NCT05405231", "title": "Connecting National Guard Service Members Through Education in Crisis Line Facilitation Training", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide" ], "interventions": [ { "name": "Crisis Line Facilitation (CLF)", "type": "BEHAVIORAL" }, { "name": "Passive Implementation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 538, "start_date": "2023-02-11", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05405231" }, { "nct_id": "NCT06376695", "title": "Radicle GI Health 24: A Study of Health and Wellness Products on GI Health and Related Health Outcomes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Abdominal Pain", "GI Disorders", "Digestion" ], "interventions": [ { "name": "Radicle GI Health Placebo Control Form 1", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 1.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control Form 2", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 2.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control Form 3", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 3.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control Form 4", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 4.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control Form 5", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 5.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control Form 7", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 7.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control 7.2", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 7.2.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control 7.3.0", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 7.3.1 Usage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Placebo Control 7.4.0", "type": "DIETARY_SUPPLEMENT" }, { "name": "Radicle GI Health Active Study Product 7.4.1 Usage", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Radicle Science", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "105 Years", "sex": "ALL", "summary": "21 Years to 105 Years" }, "enrollment_count": 4607, "start_date": "2024-04-29", "completion_date": "2025-06-05", "has_results": false, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 1, "location_summary": "Del Mar, California", "locations": [ { "city": "Del Mar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06376695" }, { "nct_id": "NCT00589875", "title": "Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Malignant Glioma", "Glioblastoma Multiforme", "Anaplastic Astrocytoma", "High Grade Glioma" ], "interventions": [ { "name": "CAN-2409", "type": "BIOLOGICAL" }, { "name": "Valacyclovir", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "Candel Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2007-03", "completion_date": "2016-08", "has_results": true, "last_update_posted_date": "2024-04-03", "last_synced_at": "2026-10-25T03:30:20.685Z", "location_count": 4, "location_summary": "Duarte, California • Chicago, Illinois • Columbus, Ohio + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00589875" } ] }